Evaluation of Extra-Prostatic Extension on Deep Learning-Reconstructed High-Resolution Thin-Slice T2-Weighted Images in Patients with Prostate Cancer.
Mingyu KimSeung Ho KimSujin HongYeon Jung KimHye Ri KimJoo Yeon KimPublished in: Cancers (2024)
The aim of this study was to compare diagnostic performance for extra-prostatic extension (EPE) and image quality among three image datasets: conventional T2-weighted images (T2WI conv , slice thickness, 3 mm) and high-resolution thin-slice T2WI (T2WI HR , 2 mm), with and without deep learning reconstruction (DLR) in patients with prostatic cancer (PCa). A total of 88 consecutive patients (28 EPE-positive and 60 negative) diagnosed with PCa via radical prostatectomy who had undergone 3T-MRI were included. Two independent reviewers performed a crossover review in three sessions, in which each reviewer recorded five-point confidence scores for the presence of EPE and image quality using a five-point Likert scale. Pathologic topographic maps served as the reference standard. For both reviewers, T2WI conv showed better diagnostic performance than T2WI HR with and without DLR (AUCs, in order, for reviewer 1, 0.883, 0.806, and 0.772, p = 0.0006; for reviewer 2, 0.803, 0.762, and 0.745, p = 0.022). The image quality was also the best in T2WI conv , followed by T2WI HR with DLR and T2WI HR without DLR for both reviewers (median, in order, 3, 4, and 5, p < 0.0001). In conclusion, T2WI conv was optimal in regard to image quality and diagnostic performance for the evaluation of EPE in patients with PCa.
Keyphrases
- image quality
- radical prostatectomy
- deep learning
- prostate cancer
- computed tomography
- high resolution
- convolutional neural network
- dual energy
- contrast enhanced
- magnetic resonance imaging
- magnetic resonance
- artificial intelligence
- optical coherence tomography
- end stage renal disease
- machine learning
- squamous cell carcinoma
- randomized controlled trial
- benign prostatic hyperplasia
- clinical trial
- chronic kidney disease
- mass spectrometry
- neoadjuvant chemotherapy
- newly diagnosed
- lymph node
- tandem mass spectrometry
- patient reported outcomes
- patient reported
- study protocol
- liquid chromatography